IGF1-AS body size locus · Insulin-like Growth Factor 1 Antisense · Dog height gene variant · IGF1-associated size variation · Körpergrößen-Genvariante IGF1-AS
This genetic variation affects a non-coding antisense RNA molecule (IGF1-AS) that regulates the expression of Insulin-like Growth Factor 1, a key hormone controlling skeletal growth. This variation influences how much of the hormone is produced, directly impacting the development of the skeletal and muscular systems. It is a natural genetic regulator of physical stature rather than a disease or medical disorder.
Owners will notice differences in the dog's overall height and skeletal size as they grow from puppyhood into adulthood. There are no symptoms of illness or physical discomfort, as this variation simply determines whether a dog will naturally be on the smaller or larger side of their breed's spectrum.
Because this is a normal genetic variation influencing body size and not a medical condition, no treatment is required. There are no associated medical costs, resulting in an expected lifetime treatment cost of 0 EUR.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the General / metabolic.